Rapid Acting Insulins Market, Global Outlook and Forecast 2022-2028

Abstract
Rapid Acting Insulins are usually taken before or with a meal. They act very quickly to minimise the rise in blood sugar which follows eating. Rapid acting insulins can be used for both type 1 and type 2 diabetes, injected or delivered via an insulin pump.
This report contains market size and forecasts of Rapid Acting Insulins in Global, including the following market information:

Global Rapid Acting Insulins Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Rapid Acting Insulins market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Lispro Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Rapid Acting Insulins include Eli Lilly, Novo Nordisk and Sanofi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Rapid Acting Insulins companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:
Global Rapid Acting Insulins Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Rapid Acting Insulins Market Segment Percentages, by Type, 2021 (%)
Lispro
Aspart (NovoLog)
Glulisine (Apidra)
Global Rapid Acting Insulins Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Rapid Acting Insulins Market Segment Percentages, by Application, 2021 (%)
Type 1 Diabetes
Type 2 Diabetes
Global Rapid Acting Insulins Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Rapid Acting Insulins Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rapid Acting Insulins revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Rapid Acting Insulins revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eli Lilly
Novo Nordisk
Sanofi

Content
Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Rapid Acting Insulins Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Rapid Acting Insulins Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Rapid Acting Insulins Overall Market Size
2.1 Global Rapid Acting Insulins Market Size: 2021 VS 2028
2.2 Global Rapid Acting Insulins Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Rapid Acting Insulins Players in Global Market
3.2 Top Global Rapid Acting Insulins Companies Ranked by Revenue
3.3 Global Rapid Acting Insulins Revenue by Companies
3.4 Top 3 and Top 5 Rapid Acting Insulins Companies in Global Market, by Revenue in 2021
3.5 Global Companies Rapid Acting Insulins Product Type
3.6 Tier 1, Tier 2 and Tier 3 Rapid Acting Insulins Players in Global Market
3.6.1 List of Global Tier 1 Rapid Acting Insulins Companies
3.6.2 List of Global Tier 2 and Tier 3 Rapid Acting Insulins Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Rapid Acting Insulins Market Size Markets, 2021 & 2028
4.1.2 Lispro
4.1.3 Aspart (NovoLog)
4.1.4 Glulisine (Apidra)
4.2 By Type - Global Rapid Acting Insulins Revenue & Forecasts
4.2.1 By Type - Global Rapid Acting Insulins Revenue, 2017-2022
4.2.2 By Type - Global Rapid Acting Insulins Revenue, 2023-2028
4.2.3 By Type - Global Rapid Acting Insulins Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Rapid Acting Insulins Market Size, 2021 & 2028
5.1.2 Type 1 Diabetes
5.1.3 Type 2 Diabetes
5.2 By Application - Global Rapid Acting Insulins Revenue & Forecasts
5.2.1 By Application - Global Rapid Acting Insulins Revenue, 2017-2022
5.2.2 By Application - Global Rapid Acting Insulins Revenue, 2023-2028
5.2.3 By Application - Global Rapid Acting Insulins Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Rapid Acting Insulins Market Size, 2021 & 2028
6.2 By Region - Global Rapid Acting Insulins Revenue & Forecasts
6.2.1 By Region - Global Rapid Acting Insulins Revenue, 2017-2022
6.2.2 By Region - Global Rapid Acting Insulins Revenue, 2023-2028
6.2.3 By Region - Global Rapid Acting Insulins Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Rapid Acting Insulins Revenue, 2017-2028
6.3.2 US Rapid Acting Insulins Market Size, 2017-2028
6.3.3 Canada Rapid Acting Insulins Market Size, 2017-2028
6.3.4 Mexico Rapid Acting Insulins Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Rapid Acting Insulins Revenue, 2017-2028
6.4.2 Germany Rapid Acting Insulins Market Size, 2017-2028
6.4.3 France Rapid Acting Insulins Market Size, 2017-2028
6.4.4 U.K. Rapid Acting Insulins Market Size, 2017-2028
6.4.5 Italy Rapid Acting Insulins Market Size, 2017-2028
6.4.6 Russia Rapid Acting Insulins Market Size, 2017-2028
6.4.7 Nordic Countries Rapid Acting Insulins Market Size, 2017-2028
6.4.8 Benelux Rapid Acting Insulins Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Rapid Acting Insulins Revenue, 2017-2028
6.5.2 China Rapid Acting Insulins Market Size, 2017-2028
6.5.3 Japan Rapid Acting Insulins Market Size, 2017-2028
6.5.4 South Korea Rapid Acting Insulins Market Size, 2017-2028
6.5.5 Southeast Asia Rapid Acting Insulins Market Size, 2017-2028
6.5.6 India Rapid Acting Insulins Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Rapid Acting Insulins Revenue, 2017-2028
6.6.2 Brazil Rapid Acting Insulins Market Size, 2017-2028
6.6.3 Argentina Rapid Acting Insulins Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Rapid Acting Insulins Revenue, 2017-2028
6.7.2 Turkey Rapid Acting Insulins Market Size, 2017-2028
6.7.3 Israel Rapid Acting Insulins Market Size, 2017-2028
6.7.4 Saudi Arabia Rapid Acting Insulins Market Size, 2017-2028
6.7.5 UAE Rapid Acting Insulins Market Size, 2017-2028
7 Players Profiles
7.1 Eli Lilly
7.1.1 Eli Lilly Corporate Summary
7.1.2 Eli Lilly Business Overview
7.1.3 Eli Lilly Rapid Acting Insulins Major Product Offerings
7.1.4 Eli Lilly Rapid Acting Insulins Revenue in Global Market (2017-2022)
7.1.5 Eli Lilly Key News
7.2 Novo Nordisk
7.2.1 Novo Nordisk Corporate Summary
7.2.2 Novo Nordisk Business Overview
7.2.3 Novo Nordisk Rapid Acting Insulins Major Product Offerings
7.2.4 Novo Nordisk Rapid Acting Insulins Revenue in Global Market (2017-2022)
7.2.5 Novo Nordisk Key News
7.3 Sanofi
7.3.1 Sanofi Corporate Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Rapid Acting Insulins Major Product Offerings
7.3.4 Sanofi Rapid Acting Insulins Revenue in Global Market (2017-2022)
7.3.5 Sanofi Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Rapid Acting Insulins Market Opportunities & Trends in Global Market
Table 2. Rapid Acting Insulins Market Drivers in Global Market
Table 3. Rapid Acting Insulins Market Restraints in Global Market
Table 4. Key Players of Rapid Acting Insulins in Global Market
Table 5. Top Rapid Acting Insulins Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Rapid Acting Insulins Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Rapid Acting Insulins Revenue Share by Companies, 2017-2022
Table 8. Global Companies Rapid Acting Insulins Product Type
Table 9. List of Global Tier 1 Rapid Acting Insulins Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Rapid Acting Insulins Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Rapid Acting Insulins Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Rapid Acting Insulins Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Rapid Acting Insulins Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Rapid Acting Insulins Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Rapid Acting Insulins Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Rapid Acting Insulins Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Rapid Acting Insulins Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Rapid Acting Insulins Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Rapid Acting Insulins Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Rapid Acting Insulins Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Rapid Acting Insulins Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Rapid Acting Insulins Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Rapid Acting Insulins Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Rapid Acting Insulins Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Rapid Acting Insulins Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Rapid Acting Insulins Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Rapid Acting Insulins Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Rapid Acting Insulins Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Rapid Acting Insulins Revenue, (US$, Mn), 2023-2028
Table 30. Eli Lilly Corporate Summary
Table 31. Eli Lilly Rapid Acting Insulins Product Offerings
Table 32. Eli Lilly Rapid Acting Insulins Revenue (US$, Mn), (2017-2022)
Table 33. Novo Nordisk Corporate Summary
Table 34. Novo Nordisk Rapid Acting Insulins Product Offerings
Table 35. Novo Nordisk Rapid Acting Insulins Revenue (US$, Mn), (2017-2022)
Table 36. Sanofi Corporate Summary
Table 37. Sanofi Rapid Acting Insulins Product Offerings
Table 38. Sanofi Rapid Acting Insulins Revenue (US$, Mn), (2017-2022)

List of Figures
Figure 1. Rapid Acting Insulins Segment by Type in 2021
Figure 2. Rapid Acting Insulins Segment by Application in 2021
Figure 3. Global Rapid Acting Insulins Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Rapid Acting Insulins Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Rapid Acting Insulins Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Rapid Acting Insulins Revenue in 2021
Figure 8. By Type - Global Rapid Acting Insulins Revenue Market Share, 2017-2028
Figure 9. By Application - Global Rapid Acting Insulins Revenue Market Share, 2017-2028
Figure 10. By Region - Global Rapid Acting Insulins Revenue Market Share, 2017-2028
Figure 11. By Country - North America Rapid Acting Insulins Revenue Market Share, 2017-2028
Figure 12. US Rapid Acting Insulins Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Rapid Acting Insulins Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Rapid Acting Insulins Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Rapid Acting Insulins Revenue Market Share, 2017-2028
Figure 16. Germany Rapid Acting Insulins Revenue, (US$, Mn), 2017-2028
Figure 17. France Rapid Acting Insulins Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Rapid Acting Insulins Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Rapid Acting Insulins Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Rapid Acting Insulins Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Rapid Acting Insulins Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Rapid Acting Insulins Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Rapid Acting Insulins Revenue Market Share, 2017-2028
Figure 24. China Rapid Acting Insulins Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Rapid Acting Insulins Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Rapid Acting Insulins Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Rapid Acting Insulins Revenue, (US$, Mn), 2017-2028
Figure 28. India Rapid Acting Insulins Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Rapid Acting Insulins Revenue Market Share, 2017-2028
Figure 30. Brazil Rapid Acting Insulins Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Rapid Acting Insulins Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Rapid Acting Insulins Revenue Market Share, 2017-2028
Figure 33. Turkey Rapid Acting Insulins Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Rapid Acting Insulins Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Rapid Acting Insulins Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Rapid Acting Insulins Revenue, (US$, Mn), 2017-2028
Figure 37. Eli Lilly Rapid Acting Insulins Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novo Nordisk Rapid Acting Insulins Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Sanofi Rapid Acting Insulins Revenue Year Over Year Growth (US$, Mn) & (2017-2022)